The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vertex Pharmaceuticals, Inc shares valued at $1,554,810 were sold by WAGNER CHARLES F JR on Nov 11 ’24. At $518.27 per share, WAGNER CHARLES F JR sold 3,000 shares. The insider’s holdings dropped to 44,137 shares worth approximately $21.83 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kewalramani Reshma sold 15,198 shares, netting a total of over 7,826,970 in proceeds. Following the sale of shares at $515.00 each, the insider now holds 75,772 shares.
Before that, Kewalramani Reshma had added 15,198 shares to its account. In a trade valued at $7,826,970, the Officer bought Vertex Pharmaceuticals, Inc shares for $515.00 each.
As published in their initiating research note from Scotiabank on October 16, 2024, Vertex Pharmaceuticals, Inc [VRTX] has been a Sector perform. As of August 05, 2024, Barclays has decreased its “an Overweight” rating to a “an Equal weight” for VRTX. Earlier on June 27, 2024, Redburn Atlantic initiated its rating. Their recommendation was “a Buy” for VRTX stock.
Analyzing VRTX Stock Performance
During the last five days, there has been a surge of approximately 0.20%. Over the course of the year, Vertex Pharmaceuticals, Inc shares have jumped approximately 21.56%. Shares of the company reached a 52-week high of $519.88 on 11/08/24 and a 52-week low of $391.01 on 04/18/24. A 50-day SMA is recorded $476.13, while a 200-day SMA reached $453.15. Nevertheless, trading volume fell to 0.98 million shares from 1.36 million shares the previous day.
Support And Resistance Levels for Vertex Pharmaceuticals, Inc (VRTX)
According to the 24-hour chart, there is a support level at 491.01, which, if violated, would cause prices to drop to 487.41. In the upper region, resistance lies at 498.23. The next price resistance is at 501.85. RSI (Relative Strength Index) is 55.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 8.41, which suggests the price will increase in the coming days. Percent R is at 44.54%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
